Aws Khalid Abushanab

5PUBLICATIONS
26CO-AUTHORS
Tumour immunologyRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 14, 2026
Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials.

|Jun 18, 2026
Efficacy and Safety of Tocilizumab Biosimilars Compared to Reference Tocilizumab in the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

|Jan 05, 2026
Safety and efficacy of spleen tyrosine kinase (Syk) inhibitors in the treatment of adults with persistent and chronic immune thrombocytopenia (ITP): A systematic review and meta-analysis of randomised clinical trials.

Mus'ab Theeb Mustafa, Aws Khalid Abushanab, Mahmoud Taysir Mousa

|Aug 26, 2025
Safety of alisertib in the treatment of solid and hematological cancers: A systematic review and meta-analysis of randomized controlled trials.

Zaher Mutaz Ashour, Aws Khalid Abushanab, Osama Wadah Rammaha

|May 24, 2023
The efficacy and safety of Capivasertib (AZD5363) in the treatment of patients with solid tumor: a systematic review and meta-analysis of randomized clinical trials.

Aws Khalid Abushanab, Mahmoud Taysir Mousa, Mus'ab Theeb Mustafa

Pageof 1

Frequent Collaborators

5 joint publications

Mus'ab Theeb Mustafa

3 joint publications

Mahmoud Taysir Mousa

2 joint publications

Reema Ismaeel

1 joint publications

Rana Ahmed Qawaqzeh